![]() ![]() Song appreciated the warm reception and considerate arrangements by relevant organizations and institutions in the Netherlands, and expressed a promising view for the development of Utrecht Science Park, looking forward an increasingly frequent communication and close cooperation on medical innovation and investment. The organoid technology is highly efficient in assisting human clinical trials, accurate and direct in present pharmaceutical effect, with a huge potential market.ĭr. Friso Smit made a brief introduction on the representative projects and research fields in the park, among which “organoid technology” developed by Hubrecht institution had low-cost but high-profit advantages. Since its establishment in 2016, Utrecht Science Park has built itself as a bio-tech innovative park integrated with education, research, healthcare, business, manufacture and entrepreneurship. Friso Smit presented the development of Utrecht Science Park. Van Msiswinket, Managing Director of Utrecht Life Sciences (USL) warmly welcomed PhIRDA Delegation. Friso Smit, New Business Development Manager at Utrecht Science Park in Utrecht Province, and Dr. Ms.Anna Elferink, Asia Affairs Director of Netherlands Foreign Investment Agency (NFIA) in Utrecht Province, Dr. On the morning of June, 20th, PhIRDA Delegation visited Utrecht Science Park in the Netherlands. PhIRDA Delegation paid a visit to innovative institutions and industrial parks in the Netherlands with widely-recognized reputation locally even worldly, including Utrecht Science Park, Netherlands Cancer Institute (NKI), Cancer Center Amsterdam (CCA), VU University Medical Center, CMS law firm etc. Song Ruilin, Executive President of China Pharmaceutical Innovation and Research Development Association (PhIRDA),PhIRDA Delegation of 11 representatives, arrived in the Netherlands on June 19 for a two-day friendly visit. Invited by Embassy of the Kingdom of Netherlands and Innovation Quarter, led by Dr. ![]()
0 Comments
Leave a Reply. |